Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: A comparison of fixed-beam versus arc delivery techniques

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 77-81

  Senthi, Sashendra ^a   Dahele, Max ^a   Van De Ven, Peter M ^a   Slotman, Ben J ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fibrosis; Local recurrence; Lung cancer; Stereotactic; Toxicity

Indexed keywords

ARC STEREOTACTIC ABLATIVE RADIOTHERAPY; ARTICLE; CANCER MORPHOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EARLY CANCER; FIXED BEAM STEREOTACTIC ABLATIVE RADIOTHERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR ABLATION;

FIBROSIS; LOCAL RECURRENCE; LUNG CANCER; STEREOTACTIC; TOXICITY;

HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIOSURGERY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888053554     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.08.034     Document Type: Article

References (26)

1. S. Senan Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoise Cancer 119 2013 2668 2670
2. F.J. Lagerwaard, N.E. Verstegen, C.J. Haasbeek, B.J. Slotman, M.A. Paul, and E.F. Smit Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
3. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, and K. Gomi Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
4. J. Rubins, M. Unger, and G.L. Colice Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 2007 355S 367S
5. C.H. Chiu, M.S. Chern, M.H. Wu, W.H. Hsu, Y.C. Wu, and M.H. Huang Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report J Thorac Cardiovasc Surg 125 2003 1300 1305
6. NCCN. NCCN Clinical practice guildelines in oncology: non-small cell lung cancer. Version 1.2013. Available from: http://www.nccn.com. Date accessed 01/03/12, 2013.
7. K. Huang, M. Dahele, S. Senan, M. Guckenberger, G.B. Rodrigues, and A. Ward Radiographic changes after lung stereotactic ablative radiotherapy (SABR)-can we distinguish recurrence from fibrosis? A systematic review of the literature Radiother Oncol 102 2012 335 342
8. S. Senthi, F.J. Lagerwaard, C.J. Haasbeek, B.J. Slotman, and S. Senan Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis Lancet Oncol 13 2012 802 809
9. M. Dahele, D. Palma, F. Lagerwaard, B. Slotman, and S. Senan Radiological changes after stereotactic radiotherapy for stage I lung cancer J Thorac Oncol 6 2011 1221 1228
10. W.F. Verbakel, S. Senan, J.P. Cuijpers, B.J. Slotman, and F.J. Lagerwaard Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 2009 122 124
11. C.L. Ong, W.F. Verbakel, J.P. Cuijpers, B.J. Slotman, F.J. Lagerwaard, and S. Senan Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques Radiother Oncol 97 2010 437 442
12. D.A. Palma, J. Van Sornsen de Koste, W.F. Verbakel, A. Vincent, and S. Senan Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients Int J Radiat Oncol Biol Phys 81 2011 974 978
13. C.W. Hurkmans, J.P. Cuijpers, F.J. Lagerwaard, J. Widder, U.A. van der Heide, and D. Schuring Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the quality assurance working party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
14. C.W. Hurkmans, M. van Lieshout, D. Schuring, M.J. van Heumen, J.P. Cuijpers, and F.J. Lagerwaard Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study) Int J Radiat Oncol Biol Phys 80 2011 918 927
15. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
16. D. Schuring, and C.W. Hurkmans Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose Radiat Oncol 3 2008 21
17. C.L. Ong, D. Palma, W.F. Verbakel, B.J. Slotman, and S. Senan Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity Radiother Oncol 97 2010 431 436
18. I.S. Grills, A.J. Hope, M. Guckenberger, L.L. Kestin, M. Werner-Wasik, and D. Yan A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393
19. Y. Matsuo, Y. Nagata, T. Mizowaki, K. Takayama, T. Sakamoto, and M. Sakamoto Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors Int J Clin Oncol 12 2007 356 362
20. D.A. Palma, S. Senan, C.J. Haasbeek, W.F. Verbakel, A. Vincent, and F. Lagerwaard Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques Int J Radiat Oncol Biol Phys 80 2011 506 513
21. P. Baumann, J. Nyman, M. Hoyer, G. Gagliardi, I. Lax, and B. Wennberg Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
22. T. Kimura, K. Matsuura, Y. Murakami, Y. Hashimoto, M. Kenjo, and Y. Kaneyasu CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 66 2006 483 491
23. M.G. Cosio, M. Saetta, and A. Agusti Immunologic aspects of chronic obstructive pulmonary disease N Engl J Med 360 2009 2445 2454
24. Y. Lee, S.L. Auh, Y. Wang, B. Burnette, Y. Meng, and M. Beckett Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment Blood 114 2009 589 595
25. S.A. Mattonen, D.A. Palma, C.J. Haasbeek, S. Senan, and A.D. Ward Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes Acta Oncol 52 2013 910 918
26. J. Ma, J. Zhang, S. Zhou, J.L. Hubbs, R.J. Foltz, and D.R. Hollis Association between RT-induced changes in lung tissue density and global lung function Int J Radiat Oncol Biol Phys 74 2009 781 789